550 related articles for article (PubMed ID: 19444865)
1. Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload.
Lecube A; Hernández C; Simó R
Diabetes Metab Res Rev; 2009 Jul; 25(5):403-10. PubMed ID: 19444865
[TBL] [Abstract][Full Text] [Related]
2. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
[TBL] [Abstract][Full Text] [Related]
3. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
Silva IS; Perez RM; Oliveira PV; Cantagalo MI; Dantas E; Sisti C; Figueiredo-Mendes C; Lanzoni VP; Silva A; Ferraz ML
J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
[TBL] [Abstract][Full Text] [Related]
4. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.
Valenti L; Fracanzani AL; Dongiovanni P; Bugianesi E; Marchesini G; Manzini P; Vanni E; Fargion S
Am J Gastroenterol; 2007 Jun; 102(6):1251-8. PubMed ID: 17391316
[TBL] [Abstract][Full Text] [Related]
5. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
[TBL] [Abstract][Full Text] [Related]
6. Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet.
Kato J; Kobune M; Nakamura T; Kuroiwa G; Takada K; Takimoto R; Sato Y; Fujikawa K; Takahashi M; Takayama T; Ikeda T; Niitsu Y
Cancer Res; 2001 Dec; 61(24):8697-702. PubMed ID: 11751387
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of iron status in patients with chronic hepatitis C.
Sartori M; Andorno S; La Terra G; Boldorini R; Leone F; Pittau S; Zecchina G; Aglietta M; Saglio G
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):396-401. PubMed ID: 9789136
[TBL] [Abstract][Full Text] [Related]
8. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
Fujita N; Horiike S; Sugimoto R; Tanaka H; Iwasa M; Kobayashi Y; Hasegawa K; Ma N; Kawanishi S; Adachi Y; Kaito M
Free Radic Biol Med; 2007 Feb; 42(3):353-62. PubMed ID: 17210448
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease and hepatitis C infection.
Bondini S; Younossi ZM
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
[TBL] [Abstract][Full Text] [Related]
10. Iron overload and glucose abnormalities in chronic hepatitis C virus infection: phlebotomy lowers risk of new-onset diabetes.
Mifuji-Moroka R; Iwasa M; Miyachi H; Sugimoto R; Tanaka H; Ishihara T; Fujita N; Kaito M; Kobayashi Y; Takei Y
Hepatogastroenterology; 2013 Oct; 60(127):1736-41. PubMed ID: 24634944
[TBL] [Abstract][Full Text] [Related]
11. Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C.
Di Marco V; Capra M; Gagliardotto F; Borsellino Z; Cabibi D; Barbaria F; Ferraro D; Cuccia L; Ruffo GB; Bronte F; Di Stefano R; Almasio PL; Craxì A
Haematologica; 2008 Aug; 93(8):1243-6. PubMed ID: 18556410
[TBL] [Abstract][Full Text] [Related]
12. Iron overload in patients with chronic viral hepatitis: how common is it?
Riggio O; Montagnese F; Fiore P; Folino S; Giambartolomei S; Gandin C; Merli M; Quinti I; Violante N; Caroli S; Senofonte O; Capocaccia L
Am J Gastroenterol; 1997 Aug; 92(8):1298-1301. PubMed ID: 9260793
[TBL] [Abstract][Full Text] [Related]
13. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
Rafiq N; Younossi ZM
Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
[TBL] [Abstract][Full Text] [Related]
14. [Hepatitis C virus-associated and metabolic steatosis. Different or overlapping diseases?].
Lonardo A; Loria P; Adinolfi LE; Andreana A; Ruggiero G; Carulli N
Ann Ital Med Int; 2005; 20(1):10-22. PubMed ID: 15859390
[TBL] [Abstract][Full Text] [Related]
15. Synergic effect of chronic hepatitis C infection and beta thalassemia major with marked hepatic iron overload on liver fibrosis: a retrospective cross-sectional study.
Ardalan FA; Osquei MR; Toosi MN; Irvanloo G
BMC Gastroenterol; 2004 Aug; 4():17. PubMed ID: 15307893
[TBL] [Abstract][Full Text] [Related]
16. Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C virus infection and non-alcoholic fatty liver disease.
Vecchiet J; Falasca K; Cacciatore P; Zingariello P; Dalessandro M; Marinopiccoli M; D'Amico E; Palazzi C; Petrarca C; Conti P; Pizzigallo E; Guagnano MT
Ann Clin Lab Sci; 2005; 35(4):415-22. PubMed ID: 16254258
[TBL] [Abstract][Full Text] [Related]
17. [Changes in iron metabolism in chronic hepatitis C].
Fernández Salazar L; García Buey L; Moreno Otero R
Rev Esp Enferm Dig; 1999 Aug; 91(8):583-9. PubMed ID: 10491490
[TBL] [Abstract][Full Text] [Related]
18. Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload.
Brudevold R; Hole T; Hammerstrøm J
PLoS One; 2008; 3(10):e3547. PubMed ID: 18958176
[TBL] [Abstract][Full Text] [Related]
19. Role of iron in the natural history and clinical course of hepatitis C disease.
Shedlofsky SI
Hepatogastroenterology; 1998; 45(20):349-55. PubMed ID: 9638405
[TBL] [Abstract][Full Text] [Related]
20. Alpha 1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage.
Valenti L; Dongiovanni P; Piperno A; Fracanzani AL; Maggioni M; Rametta R; Loria P; Casiraghi MA; Suigo E; Ceriani R; Remondini E; Trombini P; Fargion S
Hepatology; 2006 Oct; 44(4):857-64. PubMed ID: 17006922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
